NVS Stock - Novartis ADR

NVS Stock Chart

NVS Profile

Novartis AG (NVS) is a prominent Swiss pharmaceutical corporation specializing in the development, manufacturing, and marketing of prescription and over-the-counter medications, vaccines, and diagnostic tools. Established in 1996 and headquartered in Basel, Switzerland, Novartis operates through three primary business segments: Innovative Medicines, Sandoz (dedicated to generics and biosimilars), and Alcon (focused on eye care solutions). The company's extensive product portfolio encompasses therapies addressing diverse medical conditions such as cancer, cardiovascular diseases, respiratory ailments, neurological disorders, and infectious diseases.

Novartis is committed to advancing healthcare through robust research and development initiatives aimed at discovering and producing novel drugs and treatments. The company collaborates extensively with other pharmaceutical firms, academic institutions, and research organizations to foster innovation and expand therapeutic options for patients globally. This collaborative approach underscores Novartis's leadership in driving medical advancements and improving patient outcomes across various therapeutic areas.

With a strong emphasis on inovation and a global presence, Novartis continues to be at the forefront of pharmaceutical research, developpment, and commercialization. The company's comprehensive healthcare offerings underscore its commitment to addressing significant medical challenges and enhancing the quality of life for individuals worldwide.

NVS Revenue Chart

NVS Earnings

Analyst Ratings